These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9827451)

  • 21. Fatal acute myocardial infarction during severe thrombocytopenia in a patient with idiopathic thrombocytopenic purpura.
    Fruchter O; Blich M; Jacob G
    Am J Med Sci; 2002 May; 323(5):279-80. PubMed ID: 12018673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on.
    Bierling P; Godeau B
    Vox Sang; 2004 Jan; 86(1):8-14. PubMed ID: 14984554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immune globulin and aseptic meningitis.
    Rao SP; Teitlebaum J; Miller ST
    Am J Dis Child; 1992 May; 146(5):539-40. PubMed ID: 1306046
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute renal failure and intravenous immune globulin: sucrose nephropathy in disguise?
    Perazella MA; Cayco AV
    Am J Ther; 1998 Nov; 5(6):399-403. PubMed ID: 10099084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
    Chun NS; Savani B; Seder RH; Taplin ME
    Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe thromboembolic complications associated with the administration of intravenous immunoglobulins.
    Gómez Pérez M; Hernández Segurado M; Bonilla Porras M; Bécares Martínez J
    Farm Hosp; 2012; 36(3):166-7. PubMed ID: 22118762
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravenous immunoglobulin therapy and renal dysfunction.
    Windrum P; Bharucha C; Desai ZR
    Br J Haematol; 1998 Jun; 101(3):592. PubMed ID: 9633907
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal toxicity of intravenous immunoglobulin.
    Stewart RR; Winney RJ; Cash JD
    Vox Sang; 1993; 65(3):244. PubMed ID: 8249370
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous immunoglobulin-related acute coronary syndrome and coronary angiography in idiopathic thrombocytopenic purpura--a case report and literature review.
    Crouch ED; Watson LE
    Angiology; 2002; 53(1):113-7. PubMed ID: 11863304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute renal failure following intravenous immunoglobulin therapy in a HIV-infected patient.
    Metallidis S; Papaioannou M; Bokolas G; Kollaras P; Gogou V; Nikolaidis P
    Clin Nephrol; 2009 Feb; 71(2):196-7. PubMed ID: 19203515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The renal risks of high-dose intravenous immunoglobulin treatment.
    Stahl M; Schifferli JA
    Nephrol Dial Transplant; 1998 Sep; 13(9):2182-5. PubMed ID: 9761490
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute cerebellar infarction associated with intravenous gammaglobulin treatment in idiopathic thrombocytopenic purpura.
    Choi WJ; Kim MJ; Kim C; Sohn JH; Choi HC
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e9-11. PubMed ID: 22749629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy.
    Mohamed M; Bates G; Eastley B
    Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of intravenous immunoglobulins in pediatric diseases.
    Ramasubramanian KV; Kumar A; Kabra SK; Seth V
    Indian Pediatr; 1999 Jan; 36(1):51-63. PubMed ID: 10709123
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment in idiopathic thrombocytopenic purpura in the elderly: about a retrospective study.
    Zulfiqar AA; Novella JL; Mahmoudi R; Pennaforte JL; Andres E
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Jun; 14(2):151-7. PubMed ID: 27277147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.
    Rubinstein PG; Chen YH
    Am J Hematol; 2008 Aug; 83(8):684-5. PubMed ID: 18508323
    [No Abstract]   [Full Text] [Related]  

  • 37. Alternatives to intravenous immunoglobulins in the treatment of immune thrombocytopenic purpura.
    David M; Chevalier I
    Vox Sang; 2002 Aug; 83 Suppl 1():443-5. PubMed ID: 12617183
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous immunoglobulin or megadose methylprednisolone for the treatment of idiopathic thrombocytopenic purpura.
    Ozsoylu S
    Am J Pediatr Hematol Oncol; 1991; 13(3):364-5. PubMed ID: 1817495
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous immune globulin use in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1992 Jan; 146(2):121-4. PubMed ID: 1735037
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of severe thrombocytopenia with intravenous immunoglobulins and corticosteroids in a patient receiving continuous ambulatory peritoneal dialysis.
    Sugiyama H; Satoh M; Odawara M; Ichikawa H; Maruyama K; Hashimoto M; Matsuda M; Nagake Y; Kashihara N; Makino H
    Nephron; 1997; 77(3):371-2. PubMed ID: 9375840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.